Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial

Pascal Vranckx, Marco Valgimigli, Ayodele Odutayo, Patrick W. Serruys, Christian Hamm, Philippe Gabriel Steg, Dik Heg, Eugene P. Mc Fadden, Yoshinobu Onuma, Edouard Benit, Luc Janssens, Roberto Diletti, Maurizio Ferrario, Kurt Huber, Lorenz Räber, Stephan Windecker, Peter Jüni, Unknown

Open source

DOI: 10.1161/jaha.119.015560
Published: 2021-09-21
Container: Journal of the American Heart Association
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/jaha.119.015560,
  title = {Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial},
  author = {Pascal Vranckx and Marco Valgimigli and Ayodele Odutayo and Patrick W. Serruys and Christian Hamm and Philippe Gabriel Steg and Dik Heg and Eugene P. Mc Fadden and Yoshinobu Onuma and Edouard Benit and Luc Janssens and Roberto Diletti and Maurizio Ferrario and Kurt Huber and Lorenz Räber and Stephan Windecker and Peter Jüni and Unknown},
  year = {2021},
  journal = {Journal of the American Heart Association},
  doi = {10.1161/jaha.119.015560},
  url = {https://doi.org/10.1161/jaha.119.015560}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial
AU  - Pascal Vranckx
AU  - Marco Valgimigli
AU  - Ayodele Odutayo
AU  - Patrick W. Serruys
AU  - Christian Hamm
AU  - Philippe Gabriel Steg
AU  - Dik Heg
AU  - Eugene P. Mc Fadden
AU  - Yoshinobu Onuma
AU  - Edouard Benit
AU  - Luc Janssens
AU  - Roberto Diletti
AU  - Maurizio Ferrario
AU  - Kurt Huber
AU  - Lorenz Räber
AU  - Stephan Windecker
AU  - Peter Jüni
AU  - Unknown
PY  - 2021
JO  - Journal of the American Heart Association
DO  - 10.1161/jaha.119.015560
UR  - https://doi.org/10.1161/jaha.119.015560
ER  -

APA

Vranckx, P., Valgimigli, M., Odutayo, A., Serruys, P. W., Hamm, C., Steg, P. G., Heg, D., Fadden, E. P. M., Onuma, Y., Benit, E., Janssens, L., Diletti, R., Ferrario, M., Huber, K., Räber, L., Windecker, S., Jüni, P., & Unknown (2021). Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial. Journal of the American Heart Association. https://doi.org/10.1161/jaha.119.015560

Source records

crossref · retrieved 2026-09-25T22:40:30.073Z